Granger causality connectivity analysis of persistent atrial fibrillation dynamics reveals posterior wall mechanistic insights

Granger causality connectivity analysis of persistent atrial fibrillation dynamics reveals posterior wall mechanistic insights

Background: Adjunctive posterior wall isolation (PWI) to pulmonary vein isolation (PVI) has not demonstrated convincing benefit during atrial fibrillation (AF) ablation. To provide mechanistic insight for null PWI trials, we undertook Granger causality (GC) analysis of noncontact left atrial (LA) el...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph Barker, MRes, Arunashis Sau, PhD, Nikesh Bajaj, PhD, Alex Jenkins, MPhys, Alex Sharp, MRCP, Xili Shi, PhD, Xinyang Li, PhD, Nabeela Karim, PhD, Balvinder Handa, PhD, Richard Chambers, MSc, Timothy Betts, PhD, Nicholas S. Peters, MD, FHRS, Tom Wong, MD, Fu Siong Ng, PhD, FHRS
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Heart Rhythm O2
Subjects:
Atrial fibrillation
Granger causality
Posterior wall isolation
Pulmonary vein isolation
Mechanism
Online Access:http://www.sciencedirect.com/science/article/pii/S2666501825001527
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Adjunctive posterior wall isolation (PWI) to pulmonary vein isolation (PVI) has not demonstrated convincing benefit during atrial fibrillation (AF) ablation. To provide mechanistic insight for null PWI trials, we undertook Granger causality (GC) analysis of noncontact left atrial (LA) electroanatomic maps. Objective: This study aimed to apply GC to intracardiac electrograms to uncover patient-specific AF dynamics and describe a proof-of-concept approach to targeted PWI after PVI. Methods: A prospective cohort study was undertaken at Royal Brompton Hospital. Consecutive patients undergoing PVI with noncontact mapping (AcQmap; Acutus Medical) before and after PVI were included. Results: In 21 patients, causality pairing index, a GC measure of organization, was unchanged after PVI (overall, 0.087 ± 0.012 vs 0.086 ± 0.015; P = .64) or by region (posterior wall [PW], 0.084 ± 0.020 vs 0.079 ± 0.017; P = .20; rest of LA, 0.087 ± 0.013 vs 0.086 ± 0.016; P = .80). Directional dispersion, quantifying conduction heterogeneity, was lower in the PW than the rest of the LA (0.093 ± 0.036 vs 0.11 ± 0.043; P = .017) and increased after PVI (0.093 ± 0.036 vs 0.12 ± 0.043; P = .045), whereas there was no change in the rest of the LA (0.11 ± 0.034 vs 0.11 ± 0.030; P = .52). PW net outflow overall decreased after PVI (before, −0.0086 ± 0.047 vs −0.033 ± 0.054; P = .011) with a minority of patients exhibiting a net positive outflow from the PW. Conclusion: GC provides mechanistic insight into the null trials for PWI and identifies a minority of patients who may benefit. GC is positioned as a clinical decision tool to guide personalized persistent AF ablation strategies.
ISSN:2666-5018

Similar Items